ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

SAVA Cassava Sciences Inc

20,05
-0,37 (-1,81%)
29 Mär 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,37 -1,81% 20,05 01:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
20,26 20,025 20,68 20,29 20,42
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.3.202414:13GLOBECassava Sciences Announces Completion of an Interim Safety..
04.3.202415:15GLOBECassava Sciences Announces Virtual Presentation at the..
28.2.202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202415:22EDGAR2Form 8-K - Current report
28.2.202415:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
07.2.202415:20EDGAR2Form 8-K - Current report
07.2.202415:08GLOBENo Decline in Cognition Scores in Patients with Mild..
01.2.202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202422:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.1.202415:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
03.1.202422:24EDGAR2Form CERT - Certification by an exchange approving..
03.1.202422:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
03.1.202422:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
03.1.202415:10EDGAR2Form 8-K - Current report
02.1.202415:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
12.12.202315:19EDGAR2Form 8-K - Current report
12.12.202315:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
11.12.202322:18EDGAR2Form 8-K - Current report
08.12.202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.12.202322:01GLOBECassava Sciences Appoints Three New Members to its Board of..
07.11.202315:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202315:08EDGAR2Form 8-K - Current report
07.11.202315:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
06.11.202315:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
25.10.202315:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
13.10.202315:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
13.10.202305:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
05.10.202315:15GLOBECassava Sciences to Present at the Jefferies Biotech..
05.10.202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202300:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202315:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
18.9.202315:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
13.9.202322:17EDGAR2Form 8-K - Current report
11.9.202315:10GLOBECassava Sciences Announces Science Publication That Confirms..
06.9.202315:15GLOBECassava Sciences Invited to Present in Four Upcoming..
24.8.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202315:12EDGAR2Form 8-K - Current report
03.8.202315:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
05.7.202315:25EDGAR2Form 8-K - Current report
05.7.202315:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
27.6.202315:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
12.6.202315:15GLOBENew Publication Highlights Basic Science Supporting..
01.6.202315:15GLOBECassava Sciences to Present at the Jefferies Global..
11.5.202315:15GLOBECassava Sciences Completes Patient Dosing in a Randomized..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock